School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Vibha Lama

  • Department of Medicine
    Professor
  • vibha.n.lama@emory.edu
Head shot of Vibha Lama

Academic Appointment

  • Vice Chair of Research, Department of Medicine, Emory University School of Medicine
  • Augustus J. McKelvey Chair in Lung Transplantation Medicine, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, School of Medicine

Education

Degrees

  • M.D. from Dayanand Medical College & Hospital

Research

Focus

  • Pulmonary Research

    Dr. Lama's research focuses on regenerative and fibrotic pathways in the lungs that are common to several pulmonary conditions. A leader in her field, Dr. Lama is renowned nationally and internationally for her pioneering work in the fields of lung-resident mesenchymal stem cells and lung transplantation. Dr. Lama is a serially funded principal investigator with grants from the NIH, the Cystic Fibrosis Foundation, and other entities, and she has led clinical trials related to anti-fibrotic compounds. Dr. Lama has published over 80 peer-reviewed articles in her field. These include first and senior-authored papers in publications such as Journal of Clinical Investigation, Journal of Biological Chemistry, JCI Insight, American J Respiratory & Critical Care Medicine, American J Pathology, Stem Cells, and J Immunology. Among her many distinctions, she is an elected member of the American Society for Clinical Investigation (ASCI) and the American Association of Physicians (AAP).

Publications

  • Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study).
    Volume: 43 Page(s): 1468 - 1477
    09/01/2024 Authors: Combs MP; Belloli EA; Gargurevich N; Flaherty KR; Murray S; Galbn CJ; Lama VN
  • MNK-driven eIF4E phosphorylation regulates the fibrogenic transformation of mesenchymal cells and chronic lung allograft dysfunction.
    J Clin Invest Volume: 134
    08/15/2024 Authors: Walker NM; Ibuki Y; McLinden AP; Misumi K; Mitchell DC; Kleer GG; Lock AM; Vittal R; Sonenberg N; Garner AL
  • The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
    Am J Respir Crit Care Med Volume: 209 Page(s): 1360 - 1375
    06/01/2024 Authors: Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ
  • Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates.
    J Heart Lung Transplant Volume: 43 Page(s): 633 - 641
    04/01/2024 Authors: Diamond JM; Anderson MR; Cantu E; Clausen ES; Shashaty MGS; Kalman L; Oyster M; Crespo MM; Bermudez CA; Benvenuto L
  • Computed tomography-based machine learning for donor lung screening before transplantation.
    J Heart Lung Transplant Volume: 43 Page(s): 394 - 402
    03/01/2024 Authors: Ram S; Verleden SE; Kumar M; Bell AJ; Pal R; Ordies S; Vanstapel A; Dubbeldam A; Vos R; Galban S
  • The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.
    Am J Respir Crit Care Med Volume: 209 Page(s): 91 - 100
    01/01/2024 Authors: Diamond JM; Cantu E; Calfee CS; Anderson MR; Clausen ES; Shashaty MGS; Courtwright AM; Kalman L; Oyster M; Crespo MM
  • Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
    Am J Physiol Lung Cell Mol Physiol Volume: 326 Page(s): L39 - L51
    01/01/2024 Authors: Vittal R; Walker NM; McLinden AP; Braeuer RR; Ke F; Fattahi F; Combs MP; Misumi K; Aoki Y; Wheeler DS
  • Pulmonary Function and Quality of Life in Adults with Cystic Fibrosis.
    Lung Volume: 201 Page(s): 635 - 639
    12/01/2023 Authors: Smirnova N; Lowers J; Magee MJ; Auld SC; Hunt WR; Fitzpatrick A; Lama V; Kavalieratos D
  • Evaluating Inter-Rater Agreement of Radiographic Features and Diagnoses Across Lung Transplant Centers
    Volume: 42 Page(s): S149 - S149
    04/01/2023 Authors: Combs MP; McInnis M; Simpson S; Kazerooni E; Alexander B; Martinu T; Diamond J; Galban CJ; Lama V
  • CT-based Machine Learning for Donor Lung Screening Prior to Transplantation.
    medRxiv
    03/29/2023 Authors: Ram S; Verleden SE; Kumar M; Bell AJ; Pal R; Ordies S; Vanstapel A; Dubbeldam A; Vos R; Galban S
  • The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation.
    J Heart Lung Transplant Volume: 42 Page(s): 317 - 326
    03/01/2023 Authors: Aoki Y; Walker NM; Misumi K; Mimura T; Vittal R; McLinden AP; Fitzgerald L; Combs MP; Lyu D; Osterholzer JJ
  • Contemporary trends in PGD incidence, outcomes, and therapies.
    J Heart Lung Transplant Volume: 41 Page(s): 1839 - 1849
    12/01/2022 Authors: Cantu E; Diamond JM; Cevasco M; Suzuki Y; Crespo M; Clausen E; Dallara L; Ramon CV; Harmon MT; Bermudez C
  • Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury.
    Am J Respir Cell Mol Biol Volume: 67 Page(s): 459 - 470
    10/01/2022 Authors: Vittal R; Fisher AJ; Thompson EL; Cipolla EM; Gu H; Mickler EA; Varre A; Agarwal M; Kim KK; Vasko MR
  • Defibrotide Therapy for SARS-CoV-2 ARDS.
    Volume: 162 Page(s): 346 - 355
    08/01/2022 Authors: Frame D; Scappaticci GB; Braun TM; Maliarik M; Sisson TH; Pipe SW; Lawrence DA; Richardson PG; Holinstat M; Hyzy RC
  • Sustained Club Cell Injury in Mice Induces Histopathologic Features of Deployment-Related Constrictive Bronchiolitis.
    Am J Pathol Volume: 192 Page(s): 410 - 425
    03/01/2022 Authors: Teitz-Tennenbaum S; Viglianti SP; Jomma A; Palone Q; Andrews H; Selbmann KN; Lahiri S; Subbotina N; Walker N; Perl A-KT
  • Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction.
    Cells Volume: 11
    02/16/2022 Authors: Ram S; Verleden SE; Bell AJ; Hoff BA; Labaki WW; Murray S; Vanaudenaerde BM; Vos R; Verleden GM; Kazerooni EA
  • Transcription factor FOXF1 identifies compartmentally distinct mesenchymal cells with a role in lung allograft fibrogenesis.
    J Clin Invest Volume: 131
    11/01/2021 Authors: Braeuer RR; Walker NM; Misumi K; Mazzoni-Putman S; Aoki Y; Liao R; Vittal R; Kleer GG; Wheeler DS; Sexton JZ
  • Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping.
    Am J Respir Crit Care Med Volume: 204 Page(s): 967 - 976
    10/15/2021 Authors: Belloli EA; Gu T; Wang Y; Vummidi D; Lyu DM; Combs MP; Chughtai A; Murray S; Galbn CJ; Lama VN
  • Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosis.
    Am J Transplant Volume: 21 Page(s): 2360 - 2371
    07/01/2021 Authors: Wheeler DS; Misumi K; Walker NM; Vittal R; Combs MP; Aoki Y; Braeuer RR; Lama VN
  • Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
    Lancet Respir Med Volume: 9 Page(s): 601 - 612
    06/01/2021 Authors: Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
  • Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
    J Heart Lung Transplant Volume: 40 Page(s): 351 - 358
    05/01/2021 Authors: Natalini JG; Diamond JM; Porteous MK; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PD; Lama VN; McDyer JF
  • Rising PGD Incidence Parallels Increased Recipient Disease Severity
    Volume: 40 Page(s): S378 - S379
    04/01/2021 Authors: Cantu E; Diamond J; Suzuki Y; Cevasco M; Bermudez C; Dallara L; Harmon T; Ramon CV; Palmer S; Snyder L
  • Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis.
    Sci Rep Volume: 10 Page(s): 21231
    12/04/2020 Authors: Cao P; Walker NM; Braeuer RR; Mazzoni-Putman S; Aoki Y; Misumi K; Wheeler DS; Vittal R; Lama VN
  • Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.
    JCI Insight Volume: 5
    12/03/2020 Authors: Misumi K; Wheeler DS; Aoki Y; Combs MP; Braeuer RR; Higashikubo R; Li W; Kreisel D; Vittal R; Myers J
  • Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    J Heart Lung Transplant Volume: 39 Page(s): 815 - 823
    08/01/2020 Authors: Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
  • Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Am J Transplant Volume: 20 Page(s): 2198 - 2205
    08/01/2020 Authors: Cheng G-S; Selwa KE; Hatt C; Ram S; Fortuna AB; Guerriero M; Himelhoch B; McAree D; Hoffman TC; Brisson J
  • Identification of a unique temporal signature in blood and BAL associated with IPF progression.
    Sci Rep Volume: 10 Page(s): 12049
    07/21/2020 Authors: Norman KC; O'Dwyer DN; Salisbury ML; DiLillo KM; Lama VN; Xia M; Gurczynski SJ; White ES; Flaherty KR; Martinez FJ
  • Parametric Response Mapping at the Time of Potential CLAD Predicts CLAD Onset and Survival
    Volume: 39 Page(s): S163 - S164
    04/01/2020 Authors: Belloli EA; Gu T; Galban C; Murray S; Lama V
  • Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeutics.
    JCI Insight Volume: 4
    10/17/2019 Authors: Speth JM; Penke LR; Bazzill JD; Park KS; de Rubio RG; Schneider DJ; Ouchi H; Moon JJ; Keshamouni VG; Zemans RL
  • Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.
    J Heart Lung Transplant Volume: 38 Page(s): 493 - 503
    05/01/2019 Authors: Verleden GM; Glanville AR; Lease ED; Fisher AJ; Calabrese F; Corris PA; Ensor CR; Gottlieb J; Hachem RR; Lama V
  • Risk Factors for Primary Graft Dysfunction in Patients with Cystic Fibrosis Receiving Lung Transplants
    Volume: 38 Page(s): S147 - S147
    04/01/2019 Authors: Martin JA; Porteous MK; Cantu E; Lederer DJ; Snyder L; Weinacker A; Orens JB; Shah PD; Lama VN; McDyer J
  • Lung Bacterial Burden is Increased Following the Onset of Chronic Rejection
    Volume: 38 Page(s): S165 - S165
    04/01/2019 Authors: Combs MP; Wheeler DS; Luth J; Walker NM; Dickson RP; Lama VN
  • Hospital Length of Stay Following Lung Transplantation for Connective Tissue Disease-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
    Volume: 199
    01/01/2019 Authors: Natalini JG; Porteous M; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PM; Lama VN; McDyer JF; Snyder LD
  • The Role of B-Cells in an Experimental Murine of Restrictive Allograft Syndrome
    Volume: 199
    01/01/2019 Authors: Misumi K; Aoki Y; Wheeler DS; Mimura T; Kreisel D; Walker N; Lama VN
  • Decay-Accelerating Factor 1 Gene Silencing Exacerbates Alveolar Injury and Fibrotic Responses in Mice
    Volume: 199
    01/01/2019 Authors: Vittal R; Agarwal M; Wilke C; Cipolla E; Kim KK; Lama VN; Moore BB
  • Addressing Gender Inequality in Our Disciplines: Report from the Association of Pulmonary, Critical Care, and Sleep Division Chiefs.
    Volume: 15 Page(s): 1382 - 1390
    12/01/2018 Authors: Thomson CC; Riekert KA; Bates CK; Jena AB; Borok Z; McCallister JW; Schnapp LM; Lama VN; Kraft M; Davis SD
  • c-Jun N-terminal kinase (JNK)-mediated induction of mSin1 expression and mTORC2 activation in mesenchymal cells during fibrosis.
    J Biol Chem Volume: 293 Page(s): 17229 - 17239
    11/02/2018 Authors: Walker NM; Mazzoni SM; Vittal R; Fingar DC; Lama VN
  • Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury.
    JCI Insight Volume: 3
    01/25/2018 Authors: Shaver CM; Wickersham N; McNeil JB; Nagata H; Miller A; Landstreet SR; Kuck JL; Diamond JM; Lederer DJ; Kawut SM
  • Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.
    Am J Respir Crit Care Med Volume: 197 Page(s): 235 - 243
    01/15/2018 Authors: Cantu E; Diamond JM; Suzuki Y; Lasky J; Schaufler C; Lim B; Shah R; Porteous M; Lederer DJ; Kawut SM
  • InVitro Induction and InVivo Engraftment of Lung Bud Tip Progenitor Cells Derived from Human Pluripotent Stem Cells.
    Stem Cell Reports Volume: 10 Page(s): 101 - 119
    01/09/2018 Authors: Miller AJ; Hill DR; Nagy MS; Aoki Y; Dye BR; Chin AM; Huang S; Zhu F; White ES; Lama V
  • Administration of Vesicle-Encapsulated Suppressor of Cytokine Signaling 3 Inhibits Lung Epithelial Cell Transformation and Tumor Cell Function
    Volume: 197
    01/01/2018 Authors: Speth J; Penke L; Bazzill J; Arenberg DA; Moon JJ; Keshamouni VG; Lama VN; Peters-Golden M
  • Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.
    Ann Am Thorac Soc Volume: 14 Page(s): 1514 - 1522
    10/01/2017 Authors: Porteous MK; Lee JC; Lederer DJ; Palmer SM; Cantu E; Shah RJ; Bellamy SL; Lama VN; Bhorade SM; Crespo MM
  • Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.
    JCI Insight Volume: 2
    05/04/2017 Authors: Lama VN; Belperio JA; Christie JD; El-Chemaly S; Fishbein MC; Gelman AE; Hancock WW; Keshavjee S; Kreisel D; Laubach VE
  • Autocrine lysophosphatidic acid signaling activates -catenin and promotes lung allograft fibrosis.
    J Clin Invest Volume: 127 Page(s): 1517 - 1530
    04/03/2017 Authors: Cao P; Aoki Y; Badri L; Walker NM; Manning CM; Lagstein A; Fearon ER; Lama VN
  • Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.
    Am J Respir Crit Care Med Volume: 195 Page(s): 942 - 952
    04/01/2017 Authors: Belloli EA; Degtiar I; Wang X; Yanik GA; Stuckey LJ; Verleden SE; Kazerooni EA; Ross BD; Murray S; Galbn CJ
  • Identification Of Distinct Resident Mesenchymal Cell Populations In Adult Lungs
    Volume: 195
    01/01/2017 Authors: Braeuer RR; Walker N; Cao P; Aoki Y; Lama VN
  • Forkhead Box F1 Is A Negative Regulator Of Inflammatory Responses In Human Lung-Resident Mesenchymal Stem Cells
    Volume: 195
    01/01/2017 Authors: Cao P; Walker N; Aoki Y; Lama VN
  • Autotaxin As A Therapeutic Target For Bronchiolitis Obliterans After Lung Transplantation
    Volume: 195
    01/01/2017 Authors: Cao P; Aoki Y; Walker N; Lama VN
  • Forkhead Box F1 As A Novel Regulator Of Quiescence In Human Lung-Resident Mesenchymal Stem Cells
    Volume: 195
    01/01/2017 Authors: Cao P; Walker N; Aoki Y; Lama VN
  • Spirometry States the Obvious: Recognizing Bronchiolitis Obliterans Syndrome Early after Hematopoietic Cell Transplantation.
    Ann Am Thorac Soc Volume: 13 Page(s): 1883 - 1884
    11/01/2016 Authors: Belloli EA; Lama VN
  • Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
    Am J Transplant Volume: 16 Page(s): 3262 - 3269
    11/01/2016 Authors: Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD
  • The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
    J Heart Lung Transplant Volume: 35 Page(s): 500 - 507
    01/01/2009 Authors: Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S
  • Soluble CD14 and LBP as Markers for Primary Graft Dysfunction
    Volume: 35 Page(s): S314 - S315
    04/01/2016 Authors: Ramphal K; Cantu E; Porteous M; Oyster M; Kawut S; Lederer DJ; Shah R; Arcasoy S; Snyder L; Hartwig M
  • Plasma RIP3 Is Decreased in PGD after Lung Transplantation
    Volume: 35 Page(s): S87 - S87
    04/01/2016 Authors: D'Errico C; Hotz M; Cantu E; Porteous M; Oyster M; Shah R; Arcasoy S; Snyder L; Wille KM; Hartwig M
  • Redefining Primary Graft Dysfunction after Lung Transplantation
    Volume: 35 Page(s): S89 - S89
    04/01/2016 Authors: Cantu E; Diamond J; Nellen J; Beduhn B; Suzuki Y; Borders C; Lasky J; Schaufler C; Shah R; Porteous M
  • Serial Parametric Response Mapping to Diagnose Bronchiolitis Obliterans Syndrome
    Volume: 35 Page(s): S225 - S225
    04/01/2016 Authors: Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Van Raemdonck D; Verleden GM; Galban C; Lama V; Ross B
  • Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation.
    J Biol Chem Volume: 291 Page(s): 6262 - 6271
    03/18/2016 Authors: Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN
  • Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.
    Am J Transplant Volume: 16 Page(s): 833 - 840
    03/01/2016 Authors: Cantu E; Suzuki Y; Diamond JM; Ellis J; Tiwari J; Beduhn B; Nellen JR; Shah R; Meyer NJ; Lederer DJ
  • Forkhead Box F1 Is A Novel Regulator Of Autotaxin And Modulates Migration Of Human Lung-Resident Mesenchymal Stem Cells
    Volume: 193
    01/01/2016 Authors: Cao P; Walker N; Mazzoni S; Aoki Y; Lama VN
  • Carbon Monoxide Modulates Leukocyte Recruitment/infiltration In A Murine Orthotopic Single Lung Transplantation Model Of Bronchiolitis Obliterans
    Volume: 193
    01/01/2016 Authors: Aoki Y; Walker N; Pinsky D; Lama VN
  • Beta-Catenin Upregulates Fibrosis Associated Genes Through Mrna Synthesis And Stabilization In Human Lung-Resident Mesenchymal Cells
    Volume: 193
    01/01/2016 Authors: Cao P; Walker N; Aoki Y; Mazzoni S; Badri L; Fearon E; Lama VN
  • Peering into a Rejecting Lung: Can Bronchoalveolar Lavage Exosomes Provide Novel Insights?
    Am J Respir Crit Care Med Volume: 192 Page(s): 1413 - 1414
    12/15/2015 Authors: Lama VN
  • Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation.
    Am J Transplant Volume: 15 Page(s): 2188 - 2196
    08/01/2015 Authors: Shah RJ; Diamond JM; Cantu E; Flesch J; Lee JC; Lederer DJ; Lama VN; Orens J; Weinacker A; Wilkes DS
  • Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.
    Am J Respir Crit Care Med Volume: 192 Page(s): 209 - 218
    07/15/2015 Authors: Belloli EA; Wang X; Murray S; Forrester G; Weyhing A; Lin J; Ojo T; Lama VN
  • Intraalveolar Catecholamines and the Human Lung Microbiome.
    Am J Respir Crit Care Med Volume: 192 Page(s): 257 - 259
    07/15/2015 Authors: Dickson RP; Erb-Downward JR; Prescott HC; Martinez FJ; Curtis JL; Lama VN; Huffnagle GB
  • Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.
    Am J Pathol Volume: 185 Page(s): 1564 - 1574
    06/01/2015 Authors: Mimura T; Walker N; Aoki Y; Manning CM; Murdock BJ; Myers JL; Lagstein A; Osterholzer JJ; Lama VN
  • Clinical Prediction Model for PGD Among Patients With Pulmonary Hypertension
    Volume: 34 Page(s): S254 - S254
    04/01/2015 Authors: Porteous M; Lederer DJ; Palmer SM; Cantu E; Shah RJ; Bellamny S; Lama VN; Bhorade SM; Crespo MM; Wille KM
  • Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.
    Am J Respir Crit Care Med Volume: 191 Page(s): 455 - 463
    02/15/2015 Authors: Sayah DM; Mallavia B; Liu F; Ortiz-Muoz G; Caudrillier A; DerHovanessian A; Ross DJ; Lynch JP; Saggar R; Ardehali A
  • Cellular Origins of Fibrotic Lung Diseases
    Page(s): 213 - 223
    01/01/2015 Authors: Lama VN
  • Local Origin Of Collagen Expressing Cells In A Murine Model Of Orthotopic Lung Transplant Model Of Bronchiolitis Obliterans
    Volume: 191
    01/01/2015 Authors: Walker N; Mimura T; Aoki Y; Lama V
  • Impact Of Forced Vital Capacity Decline Following Lung Transplantation
    Volume: 191
    01/01/2015 Authors: Belloli EA; Wang X; Murray S; Forrester G; Lama VN
  • An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.
    Eur Respir J Volume: 44 Page(s): 1479 - 1503
    12/01/2014 Authors: Meyer KC; Raghu G; Verleden GM; Corris PA; Aurora P; Wilson KC; Brozek J; Glanville AR; ISHLT/ATS/ERS BOS Task Force Committee; ISHLT/ATS/ERS BOS Task Force Committee
  • Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid.
    J Clin Microbiol Volume: 52 Page(s): 3605 - 3613
    10/01/2014 Authors: Dickson RP; Erb-Downward JR; Prescott HC; Martinez FJ; Curtis JL; Lama VN; Huffnagle GB
  • Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Biol Blood Marrow Transplant Volume: 20 Page(s): 1592 - 1598
    10/01/2014 Authors: Galbn CJ; Boes JL; Bule M; Kitko CL; Couriel DR; Johnson TD; Lama V; Telenga ED; van den Berge M; Rehemtulla A
  • Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
    Lancet Respir Med Volume: 2 Page(s): 548 - 556
    07/01/2014 Authors: Han MK; Zhou Y; Murray S; Tayob N; Noth I; Lama VN; Moore BB; White ES; Flaherty KR; Huffnagle GB
  • Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.
    Am J Respir Crit Care Med Volume: 189 Page(s): 1564 - 1567
    06/15/2014 Authors: Shah RJ; Emtiazjoo AM; Diamond JM; Smith PA; Roe DW; Wille KM; Orens JB; Ware LB; Weinacker A; Lama VN
  • Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking
    Volume: 33 Page(s): S186 - S187
    04/01/2014 Authors: Ware LB; Roberts LJ; Diamond JM; Wickersham N; Palmer SM; Lederer D; Bhorade S; Crespo M; Weinacker A; Lama V
  • Candidate Gene Association Study in BOS
    Volume: 33 Page(s): S139 - S140
    04/01/2014 Authors: Diamond JM; Feng R; Lin W; Shah R; Cantu E; Demissie E; Rushefski M; Lederer D; Bhorade S; Crespo M
  • Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.
    Am J Respir Crit Care Med Volume: 189 Page(s): 567 - 575
    03/01/2014 Authors: Diamond JM; Akimova T; Kazi A; Shah RJ; Cantu E; Feng R; Levine MH; Kawut SM; Meyer NJ; Lee JC
  • Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
    Am J Transplant Volume: 14 Page(s): 446 - 452
    02/01/2014 Authors: Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M
  • Impact Of Donor Age On Tert Expression And Telomere Length Of Lung-Resident Mesenchymal Stromal Cells
    Volume: 189
    01/01/2014 Authors: Wadhwa A; Liu T; Walker N; Huang SK; Phan SH; Lama VN
  • Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.
    PLoS One Volume: 9 Page(s): e97214
    01/01/2014 Authors: Dickson RP; Erb-Downward JR; Freeman CM; Walker N; Scales BS; Beck JM; Martinez FJ; Curtis JL; Lama VN; Huffnagle GB
  • Cell-associated bacteria in the human lung microbiome.
    Microbiome Volume: 2 Page(s): 28
    01/01/2014 Authors: Dickson RP; Erb-Downward JR; Prescott HC; Martinez FJ; Curtis JL; Lama VN; Huffnagle GB
  • A Comparison Of Three Methods Of Identification Of Bacteria In Bronchoalveolar Lavage Specimens
    Volume: 189
    01/01/2014 Authors: Dickson RP; Erb-Downward JR; Prescott HC; Freeman CM; Walker N; Scales BS; Martinez FJ; Curtis JL; Lama VN; Huffnagle GB
  • Mtor Signaling In Mesenchymal Stromal Cells Derived From Bronchiolitis Obliterans Syndrome (bos)
    Volume: 189
    01/01/2014 Authors: Walker N; Fingar D; Lama VN
  • Airway Epithelial Cell Uptake Of Lung Mesenchymal Stromal Cell-Derived Exosomes
    Volume: 189
    01/01/2014 Authors: Manning CM; Lama VN
  • Characterization Of A Novel Robust Murine Model Of Bronchiolitis Obliterans Post-Lung Transplantation
    Volume: 189
    01/01/2014 Authors: Mimura T; Lama VN
  • The Effects Of Carbon Monoxide On Fibrotic Mesenchymal Stromal Cell Function And Mtor Pathway Activation
    Volume: 189
    01/01/2014 Authors: Walker N; Pinsky D; Lama VN
  • The Effect Of Mtor Inhibition On Fibrotic Function Of Systemic Scleroderma-Derived Mesenchymal Cells
    Volume: 189
    01/01/2014 Authors: Belloli E; Walker N; Tsou E; Kanna D; Lama VN
  • Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.
    Chest Volume: 144 Page(s): 616 - 622
    08/01/2013 Authors: Shah RJ; Diamond JM; Cantu E; Lee JC; Lederer DJ; Lama VN; Orens J; Weinacker A; Wilkes DS; Bhorade S
  • Preoperative pulmonary artery pressure and mortality after lung transplantation.
    Asian Cardiovasc Thorac Ann Volume: 21 Page(s): 326 - 330
    06/01/2013 Authors: Ohtsuka T; Flaherty KR; Lin J; Lama VN; Reddy RM; Orringer MB; Chan KM; Chang AC
  • Plasma Free Hemoglobin Potentiates the Association between Reperfusion FiO2 and Primary Graft Dysfunction after Lung Transplantation
    Volume: 32 Page(s): S42 - S43
    04/01/2013 Authors: Ware LB; Janz DR; Diamond JM; Lederer DJ; Kawut SM; Bhorade S; Palmer SM; Wille KM; Weinacker A; Lama V
  • Clinical risk factors for primary graft dysfunction after lung transplantation.
    Am J Respir Crit Care Med Volume: 187 Page(s): 527 - 534
    03/01/2013 Authors: Diamond JM; Lee JC; Kawut SM; Shah RJ; Localio AR; Bellamy SL; Lederer DJ; Cantu E; Kohl BA; Lama VN
  • Serum Complement C5a, A Marker For Primary Graft Dysfunction And Mortality After Lung Transplantation
    Volume: 187
    01/01/2013 Authors: Emtiazjoo A; Shah RJ; Wille KM; Ware LB; Lama VN; Bhorade SM; Palmer SM; Lederer DJ; Kawut SM; Christie JD
  • Use Of A Simple Prediction Model Improves Pre-Transplant Risk Stratification For Primary Graft Dysfunction After Lung Transplantation
    Volume: 187
    01/01/2013 Authors: Shah RJ; Diamond JM; Cantu E; Localio AR; Bellamy S; Flesch J; Kawut SM; Lederer DJ; Lama VN; Bhorade SM
  • The Lung Microbiota Is Distinct Following Lung Transplantation And Is Associated With Bronchiolitis Obliterans Syndrome
    Volume: 187
    01/01/2013 Authors: Dickson RP; Erb-Downward JR; Britt ZE; Walker N; Lama VN; Huffnagle GB
  • Foxf1 Transcription Factor In Acute Lung Allograft Rejection
    Volume: 187
    01/01/2013 Authors: Mimura T; Walker N; Badri L; Lagstein A; Wadhwa A; Lama VN
  • PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury.
    J Pathol Volume: 228 Page(s): 170 - 180
    10/01/2012 Authors: Osterholzer JJ; Christensen PJ; Lama V; Horowitz JC; Hattori N; Subbotina N; Cunningham A; Lin Y; Murdock BJ; Morey RE
  • Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.
    Am J Respir Crit Care Med Volume: 186 Page(s): 546 - 552
    09/15/2012 Authors: Diamond JM; Meyer NJ; Feng R; Rushefski M; Lederer DJ; Kawut SM; Lee JC; Cantu E; Shah RJ; Lama VN
  • Lysophosphatidic acid induces migration of human lung-resident mesenchymal stem cells through the -catenin pathway.
    Stem Cells Volume: 30 Page(s): 2010 - 2019
    09/01/2012 Authors: Badri L; Lama VN
  • A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
    J Heart Lung Transplant Volume: 31 Page(s): 942 - 949
    09/01/2012 Authors: Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M
  • A Panel of Lung Injury Biomarkers Enhances the Definition of Primary Graft Dysfunction (PGD) after Lung Transplantation for Early Clinical Studies
    Volume: 31 Page(s): S103 - S103
    04/01/2012 Authors: Shah RJ; Diamond JM; Kawut SM; Lee JC; Lederer DJ; Bhorade S; Crespo M; Demissie EJ; Belperio JA; Lama VN
  • Functional TLR4 Polymorphisms Are Associated with Lower Risk of Primary Graft Dysfunction (PGD) after Lung Transplantation
    Volume: 31 Page(s): S78 - S78
    04/01/2012 Authors: Diamond JM; Feng R; Meyer NJ; Shah R; Kawut SM; Lederer DJ; Lee JC; Ahya V; Cantu E; Weinacker A
  • Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allografts.
    Am J Respir Crit Care Med Volume: 185 Page(s): 77 - 84
    01/01/2012 Authors: Walker NM; Badri LN; Wadhwa A; Wettlaufer S; Peters-Golden M; Lama VN
  • Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation.
    PLoS One Volume: 7 Page(s): e51932
    01/01/2012 Authors: Diamond JM; Porteous MK; Cantu E; Meyer NJ; Shah RJ; Lederer DJ; Kawut SM; Lee J; Bellamy SL; Palmer SM
  • Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.
    Am J Respir Crit Care Med Volume: 184 Page(s): 1055 - 1061
    11/01/2011 Authors: Lederer DJ; Kawut SM; Wickersham N; Winterbottom C; Bhorade S; Palmer SM; Lee J; Diamond JM; Wille KM; Weinacker A
  • Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.
    Am J Transplant Volume: 11 Page(s): 2517 - 2522
    11/01/2011 Authors: Diamond JM; Lederer DJ; Kawut SM; Lee J; Ahya VN; Bellamy S; Palmer SM; Lama VN; Bhorade S; Crespo M
  • Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells.
    Am J Respir Cell Mol Biol Volume: 45 Page(s): 809 - 816
    10/01/2011 Authors: Badri L; Walker NM; Ohtsuka T; Wang Z; Delmar M; Flint A; Peters-Golden M; Toews GB; Pinsky DJ; Krebsbach PH
  • Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Chest Volume: 140 Page(s): 489 - 496
    08/01/2011 Authors: Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD
  • Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts.
    Am J Pathol Volume: 178 Page(s): 2461 - 2469
    06/01/2011 Authors: Walker N; Badri L; Wettlaufer S; Flint A; Sajjan U; Krebsbach PH; Keshamouni VG; Peters-Golden M; Lama VN
  • Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.
    Am J Respir Crit Care Med Volume: 183 Page(s): 1062 - 1070
    04/15/2011 Authors: Badri L; Murray S; Liu LX; Walker NM; Flint A; Wadhwa A; Chan KM; Toews GB; Pinsky DJ; Martinez FJ
  • Temporal Trends in the Prevalence of Primary Graft Dysfunction after Lung Transplantation in the Lung Transplant Outcomes Group (LTOG) Cohort
    Volume: 30 Page(s): S22 - S23
    04/01/2011 Authors: Robbins HY; Arcasoy SM; Bhorade S; Crespo MM; Kawut SM; Lama VN; Orens JB; Palmer SM; Shah PD; Shah R
  • Higher Plasma Leptin Levels Are Associated with Primary Graft Dysfunction after Lung Transplantation: The LTOG Obesity Study
    Volume: 30 Page(s): S23 - S23
    04/01/2011 Authors: Lederer DJ; Kawut SM; Wickersham N; Winterbottom C; Diamond J; Bhorade S; Palmer S; Lee J; Wille KM; Weinacker A
  • Elevated PTX3 Concentration Is Associated with Primary Graft Dysfunction after Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis
    Volume: 30 Page(s): S23 - S24
    04/01/2011 Authors: Diamond JM; Lederer D; Kawut SM; Lee J; Cantu E; Ahya V; Palmer S; Weinacker A; Bhorade S; Lama V
  • PTX3 Polymorphisms Are Associated with Primary Graft Dysfunction after Lung Transplantation
    Volume: 30 Page(s): S23 - S23
    04/01/2011 Authors: Diamond JM; Feng R; Meyer N; Lederer D; Lee J; Kawut S; Ahya V; Cantu E; Palmer S; Weinacker A
  • Local Mesenchymal Origin of Myofibroblasts in the Fibrotic Lesions in Human Lung Allografts
    Volume: 30 Page(s): S81 - S81
    04/01/2011 Authors: Walker N; Badri L; Wadhwa A; Lama V
  • Fibrotic Differentiation of Resident Mesenchymal Stromal Cells in Bronchiolitis Obliterans Syndrome
    Volume: 30 Page(s): S188 - S189
    04/01/2011 Authors: Wadhwa A; Walker N; Badri L; Chan K; Lama V
  • Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.
    Chest Volume: 139 Page(s): 782 - 787
    04/01/2011 Authors: Fang A; Studer S; Kawut SM; Ahya VN; Lee J; Wille K; Lama V; Ware L; Orens J; Weinacker A
  • Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
    Am J Transplant Volume: 11 Page(s): 561 - 567
    03/01/2011 Authors: Diamond JM; Kawut SM; Lederer DJ; Ahya VN; Kohl B; Sonett J; Palmer SM; Crespo M; Wille K; Lama VN
  • Genetic Variation In Prostaglandin E2 Family Members Is Associated With The Development Of Primary Graft Dysfunction After Lung Transplantation
    Volume: 183
    01/01/2011 Authors: Diamond JM; Feng R; Meyer NJ; Kawut SM; Lee JC; Ahya V; Cantu E; Ware L; Palmer SM; Bhorade S
  • Elevated Monocyte Chemotactic Protein-1 (MCP-1) Is Associated With Primary Graft Dysfunction Following Lung Transplantation
    Volume: 183
    01/01/2011 Authors: Shah RJ; Diamond JM; Ahya V; Arcasoy SM; Belperio JA; Bhorade S; Cantu E; Crespo M; Deutschman C; Demissie EJ
  • High-Throughput Plasma Biomarker Analysis In Ipf Reveals An Extracellular Matrix Remodeling Signature
    Volume: 183
    01/01/2011 Authors: White ES; Cornett AM; Cheng L; Dreffs AA; Yan M; Sagana RL; Booth AJ; Moore BB; Lama VN; Hogaboam CM
  • Construct validity of the definition of primary graft dysfunction after lung transplantation.
    J Heart Lung Transplant Volume: 29 Page(s): 1231 - 1239
    11/01/2010 Authors: Christie JD; Bellamy S; Ware LB; Lederer D; Hadjiliadis D; Lee J; Robinson N; Localio AR; Wille K; Lama V
  • Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation.
    J Immunol Volume: 185 Page(s): 1321 - 1329
    07/15/2010 Authors: Ohtsuka T; Changelian PS; Bous D; Noon K; Harada H; Lama VN; Pinsky DJ
  • Tacrolimus Neurotoxicity in Lung Transplant Recipients
    Volume: 29 Page(s): S121 - S121
    02/01/2010 Authors: Stuckey LJ; Florn R; Bartos C; McCullough H; Han MK; Flaherty KR; Lama VN; Gay S; Ojo T; Martinez FJ
  • Obesity Is Associated With An Increased Risk Of Primary Graft Dysfunction After Lung Transplantation: The LTOG Obesity Study
    Volume: 181
    01/01/2010 Authors: Winterbottom C; Kawut SM; Ware LB; Bhorade S; Palmer SM; Wille KM; Weinacker A; Lama VN; Crespo M; Orens JB
  • Differential Effects Of Single And Bilateral Lung Transplantation On Serum Surfactant Protein D Levels In Subjects With Idiopathic Pulmonary Fibrosis
    Volume: 181
    01/01/2010 Authors: Sims M; Beers MF; Ahya VN; Kawut SM; Lederer DJ; Palmer SM; Wille KM; Lama VN; Shah PD; Orens JB
  • Altered Prostanoid Responsiveness And Receptor Expression In Lung-resident Mesenchymal Stem Cells In Bronchiolitis Obliterans Syndrome
    Volume: 181
    01/01/2010 Authors: Walker N; Badri L; Wettlaufer SH; Peters-Golden M; Lama VN
  • Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
    Am J Respir Crit Care Med Volume: 180 Page(s): 1010 - 1015
    11/15/2009 Authors: Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V
  • Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation.
    Chest Volume: 136 Page(s): 237 - 244
    07/01/2009 Authors: Kawut SM; Okun J; Shimbo D; Lederer DJ; De Andrade J; Lama V; Shah A; Milstone A; Ware LB; Weinacker A
  • Update in lung transplantation 2008.
    Am J Respir Crit Care Med Volume: 179 Page(s): 759 - 764
    05/01/2009 Authors: Lama VN
  • Plasma Levels of Receptor for Advanced Glycation End-Products (RAGE) Are Associated with Primary Graft Dysfunction
    Volume: 28 Page(s): S308 - S309
    02/01/2009 Authors: Christie JD; Shah CV; Kawut S; Sonnett J; Abya VN; Wille K; Lama V; Orens J; Shah A; Weinacker A
  • Soluble P-Selectin and the Risk of Primary Graft Dysfunction after Lung Transplantation
    Volume: 28 Page(s): S309 - S309
    02/01/2009 Authors: Kawut SM; Okun J; Lederer DJ; Ware LB; Lama V; Welnacker A; Demissie E; Christie JD
  • Lung Resident Mesenchymal Stem Cells in Bronchoalveolar Lavage - A Novel Marker of Immune-Mediated injury In Human Lung Transplant Recipients
    Volume: 28 Page(s): S115 - S115
    02/01/2009 Authors: Lama VN; Badri L; Liu L; Chan K; Pinsky DJ; Martinez FJ; Murray S
  • Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation.
    Am J Transplant Volume: 9 Page(s): 389 - 396
    02/01/2009 Authors: Hoffman SA; Wang L; Shah CV; Ahya VN; Pochettino A; Olthoff K; Shaked A; Wille K; Lama VN; Milstone A
  • Prostaglandin E2 as an Autocrine Inhibitor of Fibrotic Functions in Lung Resident Mesenchymal Stem Cells
    Volume: 179
    01/01/2009 Authors: Lama VN; Badri LN; Walker NM; Moore BB; Toews GB; Pinsky DJ; Peters-Golden M
  • Multipotent Differentiation of Mesenchymal Stem/Progenitor Cells Isolated from Lungs of Patients with Idiopathic Pulmonary Fibrosis.
    Volume: 179
    01/01/2009 Authors: Hecker L; Jones T; Horowitz JC; Lama VN; Thannickal VJ
  • Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.
    J Immunol Volume: 181 Page(s): 4389 - 4396
    09/15/2008 Authors: Jarvinen L; Badri L; Wettlaufer S; Ohtsuka T; Standiford TJ; Toews GB; Pinsky DJ; Peters-Golden M; Lama VN
  • Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation (vol 7, pg 2573, 2007)
    AMERICAN JOURNAL OF TRANSPLANTATION Volume: 8 Page(s): 469 - 470
    02/01/2008 Authors: Covarrubias M; Ware LB; Kawut SM; De Andrade J; Milstone A; Weinacker A; Orens J; Lama V; Wille K; Bellamy S
  • Clinical risk factors for the development of primary graft dysfunction
    Volume: 27 Page(s): S67 - S68
    02/01/2008 Authors: Lee JC; Kuntz C; Kawut SM; Hadjiliadis D; Abya VN; Wille KM; Lama VN; Milstone A; Ware LB; Orens J
  • Secondary pulmonary hypertension is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis
    Volume: 27 Page(s): S84 - S84
    02/01/2008 Authors: Fang A; Studer S; Ahya VN; Hadjiliadis D; Wille K; Lama V; Milstone A; Ware L; Orens J; Weinacker J
  • Basiliximab induction in lung transplantation: A single center description of survival, acute rejection and infection
    Volume: 27 Page(s): S83 - S84
    02/01/2008 Authors: Stuckey LJ; Han MK; Florn R; Walls C; Flaherty KR; Lama VN; Gay S; Ojo T; Martinez FJ; Pickens A
  • Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation.
    Am J Transplant Volume: 7 Page(s): 2573 - 2578
    11/01/2007 Authors: Covarrubias M; Ware LB; Kawut SM; De Andrade J; Milstone A; Weinacker A; Orens J; Lama V; Wille K; Bellamy S
  • Early growth response gene-1 promotes airway allograft rejection.
    Am J Physiol Lung Cell Mol Physiol Volume: 293 Page(s): L124 - L130
    07/01/2007 Authors: Harada H; Lama VN; Badri LN; Ohtsuka T; Petrovic-Djergovic D; Liao H; Yoshikawa Y; Iwanaga K; Lau CL; Pinsky DJ
  • Lung cells from neonates show a mesenchymal stem cell phenotype.
    Am J Respir Crit Care Med Volume: 175 Page(s): 1158 - 1164
    06/01/2007 Authors: Hennrick KT; Keeton AG; Nanua S; Kijek TG; Goldsmith AM; Sajjan US; Bentley JK; Lama VN; Moore BB; Schumacher RE
  • Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Am J Respir Crit Care Med Volume: 175 Page(s): 1192 - 1198
    06/01/2007 Authors: Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
  • Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.
    J Clin Invest Volume: 117 Page(s): 989 - 996
    04/01/2007 Authors: Lama VN; Smith L; Badri L; Flint A; Andrei A-C; Murray S; Wang Z; Liao H; Toews GB; Krebsbach PH
  • Surgical patient outcomes after the increased use of bilateral lung transplantation.
    J Thorac Cardiovasc Surg Volume: 133 Page(s): 532 - 540
    02/01/2007 Authors: Chang AC; Chan KM; Lonigro RJ; Lau CL; Lama VN; Flaherty KR; Florn R; Pickens A; Murray S; Martinez FJ
  • Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.
    Am J Respir Crit Care Med Volume: 175 Page(s): 69 - 74
    01/01/2007 Authors: Christie JD; Robinson N; Ware LB; Plotnick M; De Andrade J; Lama V; Milstone A; Orens J; Weinacker A; Demissie E
  • Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
    Am J Respir Crit Care Med Volume: 174 Page(s): 803 - 809
    10/01/2006 Authors: Flaherty KR; Andrei A-C; Murray S; Fraley C; Colby TV; Travis WD; Lama V; Kazerooni EA; Gross BH; Toews GB
  • Obligatory role for interleukin-13 in obstructive lesion development in airway allografts.
    Am J Pathol Volume: 169 Page(s): 47 - 60
    07/01/2006 Authors: Lama VN; Harada H; Badri LN; Flint A; Hogaboam CM; McKenzie A; Martinez FJ; Toews GB; Moore BB; Pinsky DJ
  • The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond.
    Proc Am Thorac Soc Volume: 3 Page(s): 373 - 376
    06/01/2006 Authors: Lama VN; Phan SH
  • Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes.
    Proc Natl Acad Sci U S A Volume: 103 Page(s): 5191 - 5196
    03/28/2006 Authors: Mishra S; Fujita T; Lama VN; Nam D; Liao H; Okada M; Minamoto K; Yoshikawa Y; Harada H; Pinsky DJ
  • Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.
    Am J Respir Crit Care Med Volume: 172 Page(s): 379 - 383
    08/01/2005 Authors: Lama VN; Murray S; Mumford JA; Flaherty KR; Chang A; Toews GB; Peters-Golden M; Martinez FJ
  • Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase.
    J Exp Med Volume: 202 Page(s): 283 - 294
    07/18/2005 Authors: Minamoto K; Harada H; Lama VN; Fedarau MA; Pinsky DJ
  • Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
    Am J Respir Crit Care Med Volume: 170 Page(s): 904 - 910
    10/15/2004 Authors: Flaherty KR; King TE; Raghu G; Lynch JP; Colby TV; Travis WD; Gross BH; Kazerooni EA; Toews GB; Long Q
  • Resting and exercise physiology in interstitial lung diseases.
    Clin Chest Med Volume: 25 Page(s): 435 - v
    09/01/2004 Authors: Lama VN; Martinez FJ
  • Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia.
    Am J Respir Crit Care Med Volume: 168 Page(s): 1084 - 1090
    11/01/2003 Authors: Lama VN; Flaherty KR; Toews GB; Colby TV; Travis WD; Long Q; Murray S; Kazerooni EA; Gross BH; Lynch JP
  • Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2.
    Am J Physiol Lung Cell Mol Physiol Volume: 284 Page(s): L342 - L349
    02/01/2003 Authors: Moore BB; Peters-Golden M; Christensen PJ; Lama V; Kuziel WA; Paine R; Toews GB
  • Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent.
    Am J Respir Cell Mol Biol Volume: 27 Page(s): 752 - 758
    12/01/2002 Authors: Lama V; Moore BB; Christensen P; Toews GB; Peters-Golden M
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements